Persisting non-albicans candidemia in low birth weight neonates in a tertiary care hospital, Jammu and Kashmir

Tabindah Jahan; Anjum Farhana; Sabah Nargis

doi:10.18203/2320-6012.ijrms20231055

Authors

Tabindah Jahan Department of Microbiology, Government Medical College, Srinagar, Jammu and Kashmir, India
Anjum Farhana Department of Microbiology, Government Medical College, Srinagar, Jammu and Kashmir, India
Sabah Nargis Department of Physiology, Government Medical College, Srinagar, Jammu and Kashmir, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20231055

Keywords:

Candidiasis, Azoles, C. krusei

Abstract

Background: Neonatal candidemia is among the leading causes of mortality in neonatal intensive care units of the developing countries like India. This work aimed at determining the prevalence of candidemia, spectrum of disease, risk factors and the antifungal susceptibility in low birth weight neonates in neonatal intensive care unit (NICU)’s at a tertiary care level.

Methods: This was a prospective cross-sectional study of blood culture positive candidemia cases in neonates admitted to the neonatal intensive care unit of tertiary care hospital, SMHS, Jammu and Kashmir, India, between July 2021 to December 2022. All neonates with a clinical suspicion of candidemia with a positive blood culture (BacT alert) were identified. Patient demographics, clinical details, neonatal risk factors, and laboratory data and antifungal susceptibilities (using VITEK 2 compact system) were recorded and analyzed.

Results: A total of 680 neonatal blood culture samples were collected from NICU’s, out of which 88 (12.94%) developed candidemia. Low birth weight (33.33%), indwelling catheters (31.52%), prematurity (31.31%) and prolonged use of antibiotics were important risk factors. The commonest clinical manifestation was feed intolerance 66.1% and respiratory distress 62.2%. Non-albicans candida was seen in majority cases 86.36% with Candida krusei 77.27%. All the Candida spp. showed 100% sensitivity to voriconazole and caspofugin followed by amphotericin B, fluconazole and micafugin.

Conclusions: In this study, we focussed on determining the prevalence of candidemia in low birth weight neonates. The persistently emerging non-albicans Candida particularly Candida krusei has emerged as a big concern and needs attention for its prevention and treatment to minimize the morbidity and mortality rate.

Metrics

Metrics Loading ...

References

Million Death Study Collaborators, Bassani DG, Kumar R, Awasthi S, Morris SK, Paul VK. Causes of neonatal and child mortality in India: A nationally representative mortality survey. Lancet. 2010;376:1853 60.

Benjamin DK Jr, Stoll BJ, Fanaroff AA, McDonald SA, Oh W, Higgins RD, et al. National Institute of Child Health and Human Development Neonatal Research Network. Neonatal candidiasis among extremely low birth weight infants: Risk factors, mortality rates, and neuro developmental outcomes at 18 to 22 months. Pediatrics. 2006;117(1):84-92.

Benjamin DK, Stoll BJ, Gantz MG, Walsh MC, Sánchez PJ, Das A, et al. Neonatal candidiasis: epidemiology, risk factors, and clinical judgment. Pediatrics. 2010;126(4):865-73.

Anurekha V, Kumaravel S, Kumar P, Kumar SD, Sakti G. A Neonatal Candida Blood Stream Infection in A Tertiary Care Hospital. Indian J Neonat Med Res. 2018;6(3):PO13-6.

de Haan TR, Beckers L, de Jonge RC, Spanjaard L, van Toledo L, Pajkrt D, et al. Neonatal gram negative and Candida sepsis survival and neuro developmental outcome at the corrected age of 24 months. Plos One. 2013;8(3):59214.

Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Late-onset sepsis in very low birth weight neonates: The experience of the NICHD Neonatal Research Network. Pediatrics. 2002;110:285-91.

Oberoi JK, Wattal C, Goel N, Raveendran R, Datta S, Prasad K. Non-albicans Candida species in blood stream infections in a tertiary care hospital at New Delhi, India. Indian J Med Res. 2012;136:997-1003.

Magill SS, Shields C, Sears CL, Choti M, Merz WG. Triazole cross-resistance among Candida spp.: Case report, occurrence among bloodstream isolates, and implications for antifungal therapy. J Clin Microbiol. 2006;44:529-35.

Singhi S, Rao DS, Chakrabarti A. Candida colonization and candidemia in a pediatric intensive care unit. Pediatr Crit Care Med. 2008;9:91-5.

Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Late-onset sepsis in very low birth weight neonates: The experience of the NICHD Neonatal Research Network. Pediatrics. 2002;110:285-91.

Ariff S, Saleem AF, Soofi SB, Sajjad R. Clinical spectrum and outcomes of neonatal candidiasis in a tertiary care hospital in Karachi, Pakistan. J Infect Dev Ctries. 2011;5:216-23.

Adib SM, Bared EE, Fanous R, Kyriacos S. Practices of Lebanese gynecologists regarding treatment of recurrent vulvovaginal candidiasis. N Am J Med Sci. 2011;3:406-10.

Cleveland AA, Farley MM, Harrison LH, et al. Changes in incidence and antifungaldrug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008–2011. Clin Infect Dis. 2012;55:1352-61.

Borges RM, Soares LR, de Brito CS, de Brito DVD, Abdallah VOS, Gontijo FPP. Risk Factors Associated with Colonization by Candida spp. In Neonates Hospitalized in a Neonatal Intensive Care Unit in Brazil. Revista da SociedadeBrasileira de Medicina Tropical. 2009;42:431-5.

Bond S, Stewart DL, Bendon RW. Invasive Candida enteritis of the newborn. J Pediatr Surg. 2000;35:1496 8.

Leibovitz E. Strategies for the prevention of neonatal candidiasis. Pediatr Neonatol. 2012;53:83 9.

James M, Anuja JS, Ninan PJ. Clinical profile of neonatal candidiasis in newborn nursery. Int J Contemp Pediatr. 2018;5(2):334-7.

van Schalkwyk E, Iyaloo S, Naicker SD, MaphangaTG,Mpembe RS, Zulu TG, et al. Large outbreaks of fungal andbacterial bloodstream infections in a neonatal unit, South Africa, 2012–2016. Emerg Infect Dis. 2018;24:1204-12.

Juyal D, Sharma M, Pal S, Rathaur VK, Sharma N. Emergence of non-albicans Candida species in neonatal candidemia. N Am J Med Sci. 2013;5(9):541-5.

Xess I, Jain N, Hasan F, Mandal P, Banerjee U. Epidemiology of candidemia in a tertiary care centre of North India: 5-year study. Infection. 2007;35:256-9.

Niranjan HS. An emerging threat of Non-Albicans Candida Infection in Tertiary care neonatal intensive care units. Sch J App Med Sci. 2015;3(7B):2583-5.

Koppad B, Prakash KP. Neonatal candidiasis: clinical spectrum and epidemiology in a tertiary care centre. Int J Contemp Pediatr. 2017;4(2):438-41.

Hartung de Capriles C, Mata-Essayag S, Azpiróz A, Ponente A, Magaldi S, Pérez C, et al. Neonatal candidiasis in Venezuela: clinical and epidemiological aspects. Rev Latinoam Microbiol. 2005;47(1-2):11-20.